Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors

Clinical trial NCT07261631 · RECRUITING

Trial details

NCT number: NCT07261631
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma Non-Small Cell Lung Cancer HR+/HER2- Ductal and Lobular Breast Cancer Triple Negative Breast Cancer Colorectal Cancer Soft Tissue Sarcoma

Start date: 2025-11-24
Primary completion: 2029-05-09
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.